Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment

Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment

Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment

We investigate patients with ITP for screening of thyroid disorders and how to deal with it and effect of this on the ttt

Inclusion Criteria:

• ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively.

  • refractory ITP patients.

Exclusion Criteria:

• patients with history of thyroidectomy

  • patients with history of drug induced ITP
  • patients with history of HCV, HBV and HIV infection.
  • Patients who refuse to contribute in this study.